Toll Free: 1-888-928-9744
Published: Mar, 2015 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Longevity Biotech, Inc - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Longevity Biotech, Inc - Product Pipeline Review - 2015', provides an overview of the Longevity Biotech, Inc's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Longevity Biotech, Inc's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Longevity Biotech, Inc including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Longevity Biotech, Inc's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Longevity Biotech, Inc's pipeline products Reasons to buy - Evaluate Longevity Biotech, Inc's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Longevity Biotech, Inc in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Longevity Biotech, Inc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Longevity Biotech, Inc and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Longevity Biotech, Inc - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Longevity Biotech, Inc and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of table 4 List of Figures 4 Longevity Biotech, Inc Snapshot 5 Longevity Biotech, Inc Overview 5 Key Information 5 Key Facts 5 Longevity Biotech, Inc - Research and Development Overview 6 Key Therapeutic Areas 6 Longevity Biotech, Inc - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Longevity Biotech, Inc - Pipeline Products Glance 11 Longevity Biotech, Inc - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 Longevity Biotech, Inc - Drug Profiles 13 Synthetic Peptide to Agonize GLP1/GIP for Metabolic Disorders 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Synthetic Peptide to Inhibit Glycoprotein 41 for HIV 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Synthetic Peptides for Central Nervous System Disorders and Diabetic Neuropathy 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Synthetic Peptide 1 for Cancer 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Synthetic Peptide 2 for Cancer 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Synthetic Peptide for Metabolic Disorders 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Synthetic Peptide to Agonize VIP for Small Cell Lung Cancer 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Synthetic Peptide to Agonize VPAC2 for Pulmonary Arterial Hypertension 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Synthetic Peptide to Antagonize VPAC1 for Breast and Colon Cancer 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Longevity Biotech, Inc - Pipeline Analysis 22 Longevity Biotech, Inc - Pipeline Products by Target 22 Longevity Biotech, Inc - Pipeline Products by Route of Administration 23 Longevity Biotech, Inc - Pipeline Products by Molecule Type 24 Longevity Biotech, Inc - Pipeline Products by Mechanism of Action 25 Longevity Biotech, Inc - Dormant Projects 26 Longevity Biotech, Inc - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables Longevity Biotech, Inc, Key Information 5 Longevity Biotech, Inc, Key Facts 5 Longevity Biotech, Inc - Pipeline by Indication, 2015 8 Longevity Biotech, Inc - Pipeline by Stage of Development, 2015 9 Longevity Biotech, Inc - Monotherapy Products in Pipeline, 2015 10 Longevity Biotech, Inc - Preclinical, 2015 11 Longevity Biotech, Inc - Discovery, 2015 12 Longevity Biotech, Inc - Pipeline by Target, 2015 22 Longevity Biotech, Inc - Pipeline by Route of Administration, 2015 23 Longevity Biotech, Inc - Pipeline by Molecule Type, 2015 24 Longevity Biotech, Inc - Pipeline Products by Mechanism of Action, 2015 25 Longevity Biotech, Inc - Dormant Developmental Projects,2015 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.